about
A case report of Merkel cell carcinoma on chronic lymphocytic leukemia: differential diagnosis of coexisting lymphadenopathy and indications for early aggressive treatment.Structure of the preamyloid dimer of beta-2-microglobulin from covalent labeling and mass spectrometry.Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14.Bone marrow stromal cell-derived vascular endothelial growth factor (VEGF) rather than chronic lymphocytic leukemia (CLL) cell-derived VEGF is essential for the apoptotic resistance of cultured CLL cellsStructural insights into the pre-amyloid tetramer of β-2-microglobulin from covalent labeling and mass spectrometryRole of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia.Younger patients with chronic lymphocytic leukemia benefit from rituximab treatment: A single center study in China.Curcumin inhibits prosurvival pathways in chronic lymphocytic leukemia B cells and may overcome their stromal protection in combination with EGCG.Unique effect of Cu(II) in the metal-induced amyloid formation of β-2-microglobulinInflammation and survival pathways: chronic lymphocytic leukemia as a model system.Microenvironment interactions and B-cell receptor signaling in Chronic Lymphocytic Leukemia: Implications for disease pathogenesis and treatment.Increased β-Sheet Dynamics and D-E Loop Repositioning Are Necessary for Cu(II)-Induced Amyloid Formation by β-2-Microglobulin.Long non-coding RNAs in B-cell malignancies: a comprehensive overview.Metal binding sheds light on mechanisms of amyloid assembly.Delineating the conformational elements responsible for Cu(2+)-induced oligomerization of beta-2 microglobulin.
P2860
Q24813099-915A0CC8-A2FD-455D-8155-22E520943905Q33765266-C2BC8DFA-4476-4B2E-9F69-EB4D5BC35242Q34477348-E316A701-0649-4F55-A54E-54594EF76F93Q35136736-257992F6-5829-4DCD-BE7F-ABAE5EEEDCCCQ35146213-4E6105BE-0631-44C3-ADC4-97C3ED882D39Q36530420-499E5B6D-44F2-4E65-A3AC-83AEC90E7968Q36774671-C58560E7-DA1C-44E4-BA87-CC779ADE8B89Q37483502-73315CC4-C281-491A-8B17-B6B67B4F3C4AQ37701317-DEDF7770-4363-4676-B956-798D09DCD675Q37778876-B54A0C2F-CBB1-4188-A2A8-54CBC93E7926Q38550810-14FFAC04-66B6-40BB-BF35-56293B3CEC2BQ38974787-5467AEFE-5D7A-4A92-BC09-BF49E7D6FA97Q41694305-44C616A8-F008-4ACD-A008-CAAC7422937BQ42123429-AC35ACDE-8774-4F52-9A1D-7655D54206A6Q42145009-25C8AEA2-2171-4266-8D72-36C83E9F3AB7
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Chronic lymphocytic leukemia.
@ast
Chronic lymphocytic leukemia.
@en
Chronic lymphocytic leukemia.
@nl
type
label
Chronic lymphocytic leukemia.
@ast
Chronic lymphocytic leukemia.
@en
Chronic lymphocytic leukemia.
@nl
prefLabel
Chronic lymphocytic leukemia.
@ast
Chronic lymphocytic leukemia.
@en
Chronic lymphocytic leukemia.
@nl
P1433
P1476
Chronic lymphocytic leukemia.
@en
P2093
Keating MJ
P304
P433
5 Suppl 14
P577
1999-10-01T00:00:00Z